Financial News
Aptevo Therapeutics Inc (NQ: APVO )
0.9890
-0.1410
(-12.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Press Releases about Aptevo Therapeutics Inc
Aptevo Therapeutics' Board Chairman, Fuad El-Hibri, Announces Retirement, Effective April 1, 2022
January 21, 2022
From Aptevo Therapeutics
Via AccessWire
Topics
Retirement
Exposures
Pension
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
November 12, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Alligator Bioscience and Aptevo Therapeutics Announce a Poster Presentation of ALG.APV-527 at SITC Annual Meeting 2021
November 11, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Aptevo Therapeutics Announces Publication of a Scientific Article in Peer-Reviewed Journal, Frontiers in Aging
September 28, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights
August 12, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
From Aptevo Therapeutics
Via AccessWire
From Aptevo Therapeutics
Via AccessWire
Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
April 09, 2021
From Aptevo Therapeutics
Via AccessWire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.